Harris Dwight D, Sabe Sharif A, Broadwin Mark, Stone Christopher, Xu Cynthia, Kanuparthy Meghamsh, Malhotra Akshay, Abid M Ruhul, Sellke Frank W
Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI.
JTCVS Open. 2024 Jun 14;20:49-63. doi: 10.1016/j.xjon.2024.06.003. eCollection 2024 Aug.
Coronary artery disease remains a leading cause of morbidity and mortality worldwide. Patients with advanced coronary artery disease who are not eligible for endovascular or surgical revascularization have limited options. Extracellular vesicles have shown potential to improve myocardial function in preclinical models. Extracellular vesicles can be conditioned to modify their components. Hypoxia-conditioned extracellular vesicles have demonstrated the ability to reduce infarct size and apoptosis in small animals. Our objective is to assess the potential benefits of hypoxia-conditioned extracellular vesicles in a large animal model of coronary artery disease.
Coronary artery disease was induced in 14 Yorkshire swine by ameroid constriction of the left circumflex coronary artery. Two weeks postsurgery, swine underwent a repeat left thoracotomy for injections of hypoxia-conditioned extracellular vesicles (n = 7) or saline (control, n = 7). Five weeks later, all animals underwent terminal harvest for perfusion measurements and myocardial sectioning.
Myocardial perfusion analysis demonstrated a trend toward increase at rest and a significant increase during rapid pacing ( .09, .001). There were significant increases in activated phosphorylated endothelial nitric oxide synthase, endothelial nitric oxide synthase, phosphatidylinositol 3-kinase, phosphorylated protein kinase B, and the phosphorylated protein kinase B/protein kinase B ratio in the hypoxia-conditioned extracellular vesicles group compared with the control group (all < .05). Additionally, there was a significant decrease in the antiangiogenic proteins collagen 18 and angiostatin ( .01, = .01) in the hypoxia-conditioned extracellular vesicles group.
Intramyocardial injection of hypoxia-conditioned extracellular vesicles results in increased myocardial perfusion without a corresponding change in vessel density. Therefore, this improvement in perfusion is possibly due to changes in nitric oxide signaling. Hypoxia-conditioned extracellular vesicles represent a potential therapeutic strategy to increase myocardial perfusion in patients with advanced coronary artery disease.
冠状动脉疾病仍然是全球发病和死亡的主要原因。患有晚期冠状动脉疾病且不符合血管内或外科血运重建条件的患者选择有限。细胞外囊泡已显示出在临床前模型中改善心肌功能的潜力。细胞外囊泡可以通过预处理来改变其成分。缺氧预处理的细胞外囊泡已证明能够减少小动物的梗死面积和细胞凋亡。我们的目的是评估缺氧预处理的细胞外囊泡在大型冠状动脉疾病动物模型中的潜在益处。
通过左旋支冠状动脉的阿梅罗氏缩窄法在14只约克夏猪中诱发冠状动脉疾病。术后两周,猪接受再次左胸切开术,以注射缺氧预处理的细胞外囊泡(n = 7)或生理盐水(对照组,n = 7)。五周后,所有动物接受终末取材,进行灌注测量和心肌切片。
心肌灌注分析显示,静息时灌注有增加趋势,快速起搏时显著增加(P =.09,P =.001)。与对照组相比,缺氧预处理的细胞外囊泡组中活化的磷酸化内皮型一氧化氮合酶、内皮型一氧化氮合酶、磷脂酰肌醇3激酶、磷酸化蛋白激酶B以及磷酸化蛋白激酶B/蛋白激酶B比值均显著增加(均P <.05)。此外,缺氧预处理的细胞外囊泡组中抗血管生成蛋白18型胶原和血管抑素显著减少(P =.01,P =.01)。
心肌内注射缺氧预处理的细胞外囊泡可增加心肌灌注,而血管密度无相应变化。因此,这种灌注改善可能归因于一氧化氮信号的改变。缺氧预处理的细胞外囊泡代表了一种增加晚期冠状动脉疾病患者心肌灌注的潜在治疗策略。